Lv621
1700 积分 2025-04-02 加入
Perspective on measurable residual disease testing in acute myeloid leukemia
6小时前
已完结
The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
19小时前
已完结
Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries
19小时前
已完结
Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022
20小时前
已完结
Long-term Outcomes of Second Allogeneic Transplantation following CD7 CAR-T in Remission for T-cell Acute Lymphoblastic Leukemia or Lymphoma
3天前
已完结
Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given
10天前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
11天前
已完结
Living, not just surviving, with chronic myeloid leukemia – quality of life to the front of the line
11天前
已完结
Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report
11天前
已完结
皖公网安备34019202002308
